![]() |
市場調查報告書
商品編碼
2049144
口腔炎治療市場報告:按劑型、藥物類別、適應症和地區分類(2026-2034 年)Mouth Ulcer Treatment Market Report by Formulation, Drug Class, Indication, and Region 2026-2034 |
||||||
2025年,全球口腔潰瘍治療市場規模達20.262億美元。展望未來,IMARC Group預測,該市場在2026年至2034年間將以2.63%的複合年成長率成長,到2034年達到25.773億美元。該市場正經歷顯著成長,主要促進因素包括口腔健康問題發病率的上升、人們對治療方法的認知度提高以及對非處方藥需求的成長。製劑技術的進步、醫療保健服務的普及以及消費者對快速起效的口腔潰瘍止痛產品的偏好,也對市場成長產生了積極影響。
藥物創新
為了滿足消費者對快速緩解和促進癒合的需求,各公司正在研發速效口腔潰瘍治療產品。這些創新產品包括外用凝膠、漱口水和藥用貼劑,旨在最大限度地減輕疼痛,並在數小時內促進癒合。先進的配方專注於透過快速吸收或持續釋放,作用於目標部位,從而實現持久療效。這個趨勢源自於消費者對便利性的追求,他們希望找到既容易使用又能快速緩解症狀的產品。這些速效解決方案也深受忙碌人士的青睞,因為他們重視快速、處方箋處方的治療。此外,根據發表在《歐洲藥劑學與生物藥劑學雜誌》上的報導,基於丁香酚和硼砂的創新型口腔崩壞膜(ODF)的研發正在取得進展,它正逐漸成為治療包括口腔潰瘍在內的口腔疾病的傳統治療方法的首選替代方案,並能帶來更高效的療效。 ODF 是一種超薄、郵票大小的薄膜,便於攜帶,且對患者友好。它是一種親水性薄膜,無需用水或吞嚥,即可在舌頭或臉頰內側數秒內崩壞。這種給藥方式尤其受到吞嚥困難的兒童、老年人和需要特殊照護的患者歡迎。
電子商務通路的成長
隨著越來越多的消費者為了追求便利而轉向網路購物,口腔潰瘍治療產品的電商管道正在加速成長。線上平台提供更廣泛的產品選擇,包括各種天然產品、成藥以及當地藥局可能無法提供的特殊療法。消費者可以方便地進行價格比較和瀏覽評價,並能快速收到產品,同時享受折扣和訂閱服務。此外,線上藥局和數位健康平台的興起提高了這些療法的可及性和便利性,從而促進了線上市場的銷售。例如,根據IMARC的數據,2023年全球線上藥局市場規模達942億美元。展望未來,IMARC Group預測,到2032年,該市場規模將達到3,141億美元,2023年至2032年期間的複合年成長率(CAGR)為14.32%。此外,亞馬遜藥局(Amazon Pharmacy)於6月宣布計劃擴大其針對聯邦醫療保險(Medicare)用戶的訂閱服務。此次擴展將使超過5000萬聯邦醫療保險受益人能夠使用亞馬遜藥房的處方箋訂閱服務RxPass。
轉向天然和草本產品
由於擔心合成藥物的潛在副作用,消費者擴大選擇天然草藥產品來治療口腔潰瘍。蘆薈、洋甘菊和甘草等成分因其舒緩和癒合功效而備受青睞。這一趨勢源於人們對健康日益成長的興趣,他們更傾向於選擇符合健康生活方式的有機、無化學成分的解決方案。為了滿足不斷成長的治療方法需求,各公司正在開發植物來源產品以滿足這一趨勢,天然替代品也開始在市場上廣泛普及。根據口腔潰瘍治療市場概覽,消費者對天然草藥療法的日益成長的偏好預計將推動市場顯著成長,更多公司將投資於植物來源配方研發,以滿足消費者對有機、無化學成分解決方案日益成長的需求。例如,2023年11月,加札馬達大學牙醫學院的學生宣佈開發出一種利用果皮製成的生態酶,用於治療口腔潰瘍。研究團隊利用多種水果和植物皮加工生產生態酶,旨在促進口腔潰瘍的癒合。以大鼠為對象的實驗室研究顯示出令人鼓舞的結果,證實生態酵素貼片能夠減少口腔潰瘍傷口中的發炎細胞。該研究尚處於早期階段,目前僅在動物身上進行;需要進行更全面的研究來證實其對人體使用的安全性和有效性。
The global mouth ulcer treatment market size reached USD 2,026.2 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,577.3 Million by 2034, exhibiting a growth rate (CAGR) of 2.63% during 2026-2034. The market is experiencing significant growth mainly driven by rising incidences of oral health issues, an increased awareness of treatment options and the growing demand for over-the-counter remedies. Advancements in pharmaceutical formulations, expanding healthcare access and consumer preference for fast-acting, pain-relief products to treat mouth ulcers are also contributing positively to the market growth.
Innovation in Formulations
Companies are developing fast-acting mouth ulcer treatments to address the consumer demand for quicker relief and healing. These innovations include topical gels, oral rinses, and medicated patches designed to minimize pain and accelerate recovery within hours. Advanced formulations focus on delivering targeted action through immediate absorption or sustained release, providing long-lasting effects. This trend is driven by consumer expectations for convenience, with products that offer swift relief while being easy to apply. These rapid solutions are also appealing in busy lifestyles where quick treatment without the need for prescriptions is highly valued. Furthermore, according to an article published in the European Journal of Pharmaceutics and Biopharmaceutics in , the development of innovative eugenol and borax-based orodispersible films (ODFs) have emerged as the preferred alternative to traditional methods of treating oral diseases, including mouth ulcers, with a much more efficient results. ODFs are ultra-thin, stamp-sized, portably-used, patient-friendly, and hydrophilic films that dissolve and disintegrate within seconds on the tongue or buccal area without the need of water or swallowing. This administration is particularly prevalent among pediatric, geriatric, and special patient populations who have dysphagia.
Growth in E-Commerce Channels
Growth in e-commerce channels for mouth ulcer treatments is accelerating as more consumers shift toward online shopping for convenience. Online platforms offer a wider selection of products, including various natural, OTC, and specialized treatments, which may not be available in local pharmacies. Consumers benefit from the ease of comparing prices, reading reviews, and receiving products quickly, often with discounts or subscription services. Additionally, the rise of e-pharmacies and digital health platforms has contributed to the increased availability and accessibility of these treatments, boosting online sales in the market. For instance, according to IMARC, the global e-pharmacy market size reached US$ 94.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 314.1 Billion by 2032, exhibiting a growth rate (CAGR) of 14.32% during -2032. Furthermore, Amazon Pharmacy announced in June that it intends to expand its subscription service to enrollees of Medicare insurance plans. The expansion will be available to more than 50 million Medicare beneficiaries, who will have access to RxPass, Amazon Pharmacy's subscription prescription service
Shift Towards Natural and Herbal Products
Consumers are increasingly turning to natural and herbal products for mouth ulcer treatment due to concerns about the potential side effects of synthetic medications. Ingredients like aloe vera, chamomile, and licorice are favored for their soothing and healing properties. This shift is driven by a broader focus on wellness, as people prefer organic and chemical-free solutions that align with health-conscious lifestyles. The growing demand for such treatments is encouraging companies to develop more plant-based products that cater to this trend, making natural alternatives widely available across the market. According to the mouth ulcer treatment market overview, this rising consumer preference for natural and herbal remedies is expected to drive significant growth, with more companies investing in plant-based formulations to meet the increasing demand for organic, chemical-free solutions. For instance, in November 2023, UGM Dentistry students announced the development of eco-enzymes from fruit peels for mouth ulcer treatment. The team processed peels from various fruits and plants into eco-enzymes, aiming to accelerate mouth ulcer healing. Laboratory research on rats showed promising results, with the eco-enzyme patch reducing inflammatory cells in mouth ulcer wounds. While the research is in early stages and tested only on animals, further comprehensive studies are required to ensure its safety and efficacy for human use.
Gel accounts for the majority of the market share
According to mouth ulcer treatment market report, gel dominate the market due to their fast-acting and targeted relief. Their easy application and ability to form a protective barrier over the ulcer make them highly effective in soothing pain and accelerating healing. Gels often contain active ingredients like antiseptics, pain relievers, and anti-inflammatory agents, providing comprehensive treatment in a single application. Their ability to stay localized at the site of the ulcer allows for longer-lasting relief compared to other forms, such as mouthwashes or lozenges. This convenience and effectiveness have led to their widespread preference among consumers.
Corticosteroids holds the largest share of the industry
Corticosteroids hold the largest share of the mouth ulcer treatment industry due to their powerful anti-inflammatory and immunosuppressive properties. These medications effectively reduce swelling, pain, and irritation associated with mouth ulcers, promoting faster healing. Corticosteroids are often prescribed for severe or recurrent cases of ulcers, such as aphthous stomatitis, where over-the-counter treatments may be less effective. Their ability to target the underlying inflammation makes them a preferred choice among healthcare professionals. Additionally, advancements in topical corticosteroid formulations, like gels and ointments, have improved patient compliance by offering localized relief with minimal systemic side effects. These factors are creating a positive mouth ulcer treatment market outlook, driving the demand for corticosteroid-based products due to their efficacy in managing severe ulcer cases.
Aphthous Stomatitis represents the leading market segment
Aphthous stomatitis, commonly known as canker sores, represents the leading segment in the mouth ulcer treatment market due to its high prevalence among individuals worldwide. This condition is characterized by recurrent, painful ulcers in the mouth, often triggered by stress, injury, or nutritional deficiencies. The demand for effective treatments, such as corticosteroids, gels, and antiseptic mouthwashes, is high as patients seek fast relief from discomfort and accelerated healing. The chronic and recurrent nature of aphthous stomatitis drives the consistent demand for both over-the-counter and prescription treatments. The mouth ulcer treatment market dynamics are further influenced by the need for innovative and accessible solutions to manage the chronic and recurrent nature of aphthous stomatitis, leading to continuous advancements in treatment options and increased competition among pharmaceutical companies. According to an article published in May 2023 by National Library of Medicine, approximately 25% of the global population is affected by recurrent aphthous stomatitis (RAS), a common oral mucosal disease. Factors such as genetics, nutritional deficiencies, stress, and immune dysfunction contribute to the condition. This high prevalence underscores the significant demand for effective treatments and preventive solutions in the market. As a result, pharmaceutical companies are focusing on developing targeted therapies that address the underlying causes of RAS while minimizing recurrence and improving patient outcomes.
North America leads the market, accounting for the largest mouth ulcer treatment market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, Latin America. According to the report, North America represents the largest regional market for mouth ulcer treatment.
North America leads the global mouth ulcer treatment market, accounting for the largest share due to the region's high awareness of oral health and access to advanced healthcare services. The prevalence of conditions like aphthous stomatitis and other oral ulcers is significant, driving the demand for both over-the-counter and prescription treatments. The region's well-established pharmaceutical industry supports the development and availability of effective treatments, such as corticosteroids, gels, and mouthwashes. Additionally, the focus on research and innovation, along with favorable healthcare reimbursement policies, boosts market growth. The increasing preference for fast-acting, pain-relief products further strengthens North America's leadership in this market. According to mouth ulcer treatment market forecast, North America is expected to continue to lead, with steady growth driven by ongoing advancements in treatment options, rising demand for innovative therapies, and increasing awareness of oral health management. For instance, in November 2023, MidAmerica Pharmaceuticals introduced Kourzeq(TM), a new FDA-approved dental paste for treating canker sores. The paste, containing triamcinolone acetonide, is designed to provide temporary relief and adjunctive treatment for oral inflammatory and ulcerative lesions. Available exclusively through telehealth via BeyondMD, Kourzeq aims to make a positive impact on those suffering from canker sores.